Soligenix, Inc. Announces Positive Clinical Results from Phase 2 Trial of Sgx945 for the …
… of Behcet’s Disease have been published in Rheumatology , in an article entitled… -December 18, 2025 at 11:52 am […]
Google News
Nature Reviews Rheumatology
Mechanistic link uncovered between EBV infection and SLE
Nature Reviews Rheumatology, Published online: 18 December 2025; doi:10.1038/s41584-025-01346-2 A new study reveals that the Epstein–Barr virus can reprogramme autoreactive
Google News
Study: Cannabis Treatment Provides Sustained Relief for Patients With Fibromyalgia
… Rheumatology. British investigators assessed the adjunctive use of cannabis-based medicinal products (CBMPs) in a cohort of 497 FM patients …
Google News
Genetic differences can affect the effectiveness of antibody therapies – News-Medical.net
Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis. Antibodies recognize and bind …
Google News
Experts link air pollution to autoimmune diseases including lupus – UPI.com
… rheumatic diseases, researchers recently reported in the journal Rheumatology. “These results point us in a new direction for understanding
Google News
Towards the elimination of rheumatic heart disease in Africa and globally – Oxford Academic
Rheumatic heart disease (RHD) is the leading acquired cardiovascular disease among children, adolescents, and young adults in low- and …
Google News
Mechanistic link uncovered between EBV infection and SLE | Nature Reviews Rheumatology
A new study reveals that the Epstein–Barr virus can reprogramme autoreactive B cells into pathogenic antigen-presenting cells in systemic lupus …
RheumNow
Hidden in Plain Sight: IBD
Hidden in Plain Sight: IBD Lindsayrtom@gm… Thu, 12/18/2025 – 08:00
Rheumatology
JAK inhibitors not associated with stunted growth in children
JAK inhibitor treatment is not associated with stunted growth in children with common inflammatory diseases, according to a research letter
Medscape
FDA Says It Will Act Quickly to Approve Sunscreen Ingredient
Bemotrizinol’s manufacturer said that it expects this ingredient to be available for use in sunscreens in the summer of 2026.
Google News
Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet’s Disease …
Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet’s Disease Published in Rheumatology (Oxford) ·
Google News
Benralizumab demonstrates durable remission, low relapse rates in EGPA – Healio
Merkel, MD, MPH, chief of the division of rheumatology, and professor of medicine and epidemiology, at the University of Pennsylvania,
Google News
Climate change impacts mental, physical health for Georgia residents – The Augusta Chronicle
Kathleen May, division chief of allergy immunology and pediatric rheumatology at the Medical College of. It’s not just the heat.
Google News
Evaluation of netrin 1 as a new biomarker in the differentiation of psoriatic arthritis from psoriasis
Rheumatologists‘ recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients’ joint symptoms. J. Dermatol.
Google News
Drug Combo Boosts Bone Health in Postmenopausal Osteoporosis – Medscape
… Rheumatology Unit, University of Verona in Verona, Italy. It was published online on December 1, 2025, in Arthritis &
PubMed
Precision and contextualization in claims-based disease activity assessment for systemic lupus erythematosus in Korean populations
J Rheum Dis. 2026 Jan 1;33(1):1-2. doi: 10.4078/jrd.2025.0148. Epub 2025 Oct 28. NO ABSTRACT PMID:41409810 | PMC:PMC12706434 | DOI:10.4078/jrd.2025.0148
PubMed
Current and future treatment of rheumatoid arthritis
J Rheum Dis. 2026 Jan 1;33(1):7-18. doi: 10.4078/jrd.2025.0034. Epub 2025 Oct 21. ABSTRACT Rheumatoid arthritis (RA) is a chronic, systemic
PubMed
Review of literature: posterior reversible encephalopathy syndrome in systemic lupus erythematosus
J Rheum Dis. 2026 Jan 1;33(1):3-6. doi: 10.4078/jrd.2025.0010. Epub 2025 Apr 21. ABSTRACT Posterior reversible encephalopathy syndrome (PRES) is a
PubMed
VEXAS syndrome in rheumatology practice: features from a multicenter cohort in north-east Italy
Front Immunol. 2025 Dec 2;16:1700737. doi: 10.3389/fimmu.2025.1700737. eCollection 2025. ABSTRACT OBJECTIVE: VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) is
PubMed
The stigmatization of patients with chronic pain due to assessed exaggeration of symptoms
Can J Pain. 2025 Dec 15;9(1):2583909. doi: 10.1080/24740527.2025.2583909. eCollection 2025. ABSTRACT Patients with chronic pain that cannot be explained by
PubMed
Cytomegalovirus retinitis during upadacitinib monotherapy for rheumatoid arthritis: a case report
J Rheum Dis. 2026 Jan 1;33(1):65-69. doi: 10.4078/jrd.2025.0019. Epub 2025 Apr 3. ABSTRACT Janus kinase inhibitors (JAKis) are associated with
PubMed
Elevated circulating interleukin-17 levels in systemic sclerosis: a meta-analysis
J Rheum Dis. 2026 Jan 1;33(1):37-45. doi: 10.4078/jrd.2025.0056. Epub 2025 Sep 1. ABSTRACT OBJECTIVE: The aim of this meta-analysis was
PubMed
Defining early axial spondyloarthritis: insights and applications of the Assessment of Spondyloarthritis International Society international consensus
J Rheum Dis. 2026 Jan 1;33(1):19-24. doi: 10.4078/jrd.2025.0077. Epub 2025 Aug 19. ABSTRACT Axial spondyloarthritis (axSpA) is a chronic inflammatory
PubMed
Analysis of circulating immune cells in patients with rheumatoid arthritis and positive for hashimoto thyroiditis antibodies
Autoimmunity. 2025 Dec;58(1):2445537. doi: 10.1080/08916934.2024.2445537. Epub 2024 Dec 29. ABSTRACT To examine the differences in the proportions of circulating peripheral
PubMed
Cardiovascular Manifestations and Immunobiology of Sarcoidosis
Arterioscler Thromb Vasc Biol. 2025 Dec 18. doi: 10.1161/ATVBAHA.125.323111. Online ahead of print. ABSTRACT Sarcoidosis is a chronic inflammatory disease
PubMed
Genetic and epigenetic insights into systemic lupus erythematosus: linking long non-coding RNA growth arrest-specific transcript 5 and interferon signature
J Rheum Dis. 2026 Jan 1;33(1):55-64. doi: 10.4078/jrd.2025.0074. Epub 2025 Jul 22. ABSTRACT OBJECTIVE: Interferon (IFN) signaling, and excessive apoptosis
PubMed
Risk of cardiovascular disease associated with use of tumor necrosis factor inhibitors in ankylosing spondylitis
J Rheum Dis. 2026 Jan 1;33(1):46-54. doi: 10.4078/jrd.2025.0070. Epub 2025 Aug 26. ABSTRACT OBJECTIVE: To examine the risk of cardiovascular